Lowering myeloid GRK2 protein could prevent this vicious cycle from establishing and thus stop vascular dysfunction by preventing, on the one hand, the pro-inflammatory shift and, on the other, the increased NADPH oxidase expression observed during obesity. This evidence concerns the gene FMO5 and obesity due to melanocortin 4 receptor deficiency.